Large-Cell Immunoblastic Lymphoma
Symptoms, Doctors, Treatments, Advances & More

Large-Cell Immunoblastic Lymphoma Overview

Save information for later
Sign Up

Learn About Large-Cell Immunoblastic Lymphoma

What is the definition of Large-Cell Immunoblastic Lymphoma?
A diffuse large B-cell lymphoma characterized by the presence of immunoblasts with uniformly round-to-oval nuclei, a prominent nucleolus, and abundant cytoplasm.
What are the alternative names for Large-Cell Immunoblastic Lymphoma?
  • Lymphoma, large-cell, immunoblastic
  • Large cell immunoblastic lymphoma
Who are the top Large-Cell Immunoblastic Lymphoma Local Doctors?
Asheesh Shipstone
Distinguished in Large-Cell Immunoblastic Lymphoma
Dr. Asheesh Shipstone
Hematology | Oncology
Distinguished in Large-Cell Immunoblastic Lymphoma
Dr. Asheesh Shipstone
Hematology | Oncology

Ballad Health Cancer Center

2202 North John B. Dennis Highway, Suite 100, 
Kingsport, TN 
423-578-8500
Languages Spoken:
English
See accepted insurances

. Dr. Shipstone is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Immunoblastic Lymphoma. His top areas of expertise are Adult Immune Thrombocytopenia, Colorectal Cancer, Hemangioma Thrombocytopenia Syndrome, and Thrombocytopenia.

Elite in Large-Cell Immunoblastic Lymphoma
Dr. Tatyana A. Feldman
Oncology | Hematology
Elite in Large-Cell Immunoblastic Lymphoma
Dr. Tatyana A. Feldman
Oncology | Hematology

HMH - John Theurer Cancer Center - Hackensack

92 2nd Street, 
Hackensack, NJ 
551-996-3033
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Tatyana Feldman is an Oncologist and a Hematologist in Hackensack, New Jersey. Dr. Feldman is rated as an Elite provider by MediFind in the treatment of Large-Cell Immunoblastic Lymphoma. Her top areas of expertise are Classical Hodgkin Lymphoma, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.

 
 
 
 
Learn about our expert tiers
Learn More
Alex Herrera
Elite in Large-Cell Immunoblastic Lymphoma
Dr. Alex Herrera
Oncology
Elite in Large-Cell Immunoblastic Lymphoma
Dr. Alex Herrera
Oncology

Alex Herrera, M.D.

1500 Duarte Rd, 
Duarte, CA 
800-826-4673
Experience:
17+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Alex Herrera is an Oncologist in Duarte, California. Dr. Herrera has been practicing medicine for over 17 years and is rated as an Elite provider by MediFind in the treatment of Large-Cell Immunoblastic Lymphoma. His top areas of expertise are Hodgkin Lymphoma, Classical Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.

View All Doctors
What are the latest Large-Cell Immunoblastic Lymphoma Clinical Trials?
Tissue Procurement For Hematolymphoid Conditions
Tissue Procurement For Hematolymphoid Conditions
Enrollment Status: Recruiting
Publish Date: October 27, 2025
Intervention Type: Other

Summary: RATIONALE: Collecting and storing samples of tissue, blood, and body fluid from patients with cancer to study in the laboratory may help the study of cancer in the future. PURPOSE: This research study is collecting and storing blood and tissue samples from patients being evaluated for hematologic cancer.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Phase I Trial of Systemic Administration of Vesicular Stomatitis Virus Genetically Engineered to Express NIS and Human Interferon, in Patients With Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia, Lymphomas, or Histiocytic/Dendritic Cell Neoplasms
Phase I Trial of Systemic Administration of Vesicular Stomatitis Virus Genetically Engineered to Express NIS and Human Interferon, in Patients With Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia, Lymphomas, or Histiocytic/Dendritic Cell Neoplasms
Who is this study for: Adult patients with Multiple Myeloma, Acute Myeloid Leukemia, or Relapsed T Cell Lymphoma
Enrollment Status: Recruiting
Publish Date: October 08, 2025
Intervention Type: Procedure, Biological, Drug
Study Drugs: Cyclophosphamide, Ruxolitinib, Recombinant Vesicular Stomatitis Virus-Expressing Human Interferon Beta and Sodium-Iodide Symporter
Study Phase: Phase 1

Summary: This phase I trial studies the best dose and side effects of the VSV-hIFNβ-NIS vaccine with or without cyclophosphamide and combinations of ipilimumab, nivolumab, and cemiplimab in treating patients with multiple myeloma, acute myeloid leukemia or lymphoma that has come back after a period of improvement (relapsed) or that does not respond to treatment (refractory). VSV-IFNβ-NIS is a modified vers...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center